We propose to study the immunohistochemical expression of BCL-2 in endometrial carcinoma reported from our institute and its correlation with hormone receptor status and transforming growth factor. This article is based on the thesis defended on September 12, 2013, in the "Tamil Nadu Dr. M.G.R. Medical University." Here, BCL2 is linked to endometrial carcinoma.